The acute broncholytic efficacy and the protective anticonstrictive effectiveness of a new beta 2-receptor stimulator, Reproterol, was tested in 16 patients with the acetylcholine (ACH) provocation test. Plethysmographic airway resistance determinations (Raw) and flow volume curves (VEmax50%/FVC) were used as assessment parameters. All patients proved susceptible to ACH provocation, in as much they demonstrated a significant rise in the Raw from 2.46 to 11.53 cm H2O/1/sec and a significant decline of the VEmax50%/FVC from 884 to 565 (ml/sec/1) following ACH administration. With Reproterol inhalation (2 puffs at 500 mu each), almost complete elimination of ACH-induced bronchial constriction was achieved. The ACH provocation with the same patients the following day, however, was almost absent 60 min after oral ingestion of 20 mg of Reproterol tablets. Dose-efficacy studies in 7 volunteers from the same group revealed a subjectively better tolerance of the 10-mg tablets, but with a correspondingly lower antibronchia constrictive efficacy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000194093 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Coronary vasomotor response incidence to intracoronary acetylcholine provocation test according to the severity of insignificant coronary artery stenosis in Korean population.
Coron Artery Dis
December 2024
Department of Biomedical Laboratory Science, Honam University, Gwangju, Korea.
Background: Coronary artery spasm (CAS) is a cause of variant angina. However, the understanding of CAS patterns in the presence of mild-to-moderate coronary artery stenosis is limited. This study aimed to evaluate the incidence and patterns of CAS in patients with insignificant coronary artery stenosis using intracoronary acetylcholine (ACH) provocation test.
View Article and Find Full Text PDFDiagnostic Yield of Comprehensive Coronary Function Testing in Patients with Angina and Unobstructed Coronary Arteries: Endotype Characterisation and Clinical Implications.
Eur Cardiol
November 2024
Department of Cardiology and Angiology, Robert Bosch Hospital Stuttgart, Germany.
Article Synopsis
- Coronary functional disorders (CFD) significantly contribute to angina in patients with non-obstructed coronary arteries (ANOCA), with different endotypes identified, such as microvascular spasm and coronary microvascular dysfunction (CMD).
- A study involving 89 ANOCA patients using comprehensive coronary functional testing (CFT) found that 91% had at least one disorder, with microvascular spasm being the most common (61%).
- The results highlighted that isolated CMD is rare and emphasized the necessity of spasm testing for diagnosing and characterizing CFD in ANOCA patients.
Effects of radial artery spasm prophylaxis on intracoronary vasomotor responses during acetylcholine spasm provocation testing.
Int J Cardiol
January 2025
Robert-Bosch-Krankenhaus, Department of Cardiology and Angiology, Stuttgart, Germany. Electronic address:
Article Synopsis
- * The research involved 372 patients with angina but non-obstructive coronary arteries, comparing results from those who received RASP vs. those who did not during ACh provocation testing.
- * Findings indicated that RASP did not significantly change the frequency or type of coronary vasomotor responses when tested with ACh, meaning it can be safely used in patients undergoing spasm testing.
Absolute coronary blood flow across different endotypes of ANOCA.
EuroIntervention
October 2024
Department of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands.
Article Synopsis
- Intracoronary continuous thermodilution is a new method to measure coronary flow and microvascular resistance, but its effectiveness in patients with angina and non-obstructive coronary arteries (ANOCA) is still unclear.
- This study involved 120 patients undergoing coronary function tests, including acetylcholine testing, to assess their coronary flow and microvascular function.
- Results showed that a high percentage of patients had positive coronary function tests, and specific measurements (Qmax and Rμ,hyper) were linked to these positive results, suggesting that the continuous thermodilution technique could help understand different ANOCA profiles better.
Factors Contributing to Coronary Microvascular Dysfunction in Patients with Angina and Non-Obstructive Coronary Artery Disease.
J Cardiovasc Dev Dis
July 2024
Department of Cardiovascular Medicine, JR Hiroshima Hospital, 3-1-36, Futabanosato, Higashi-Ku, Hiroshima 732-0057, Japan.
Background: Coronary microvascular dysfunction (CMD), characterised by a reduced coronary flow reserve (CFR) or an increased index of microcirculatory resistance (IMR), has received considerable attention as a cause of chest pain in recent years. However, the risks and causes of CMD remain unclear; therefore, effective treatment strategies have not yet been established. Heart failure or coronary artery disease (CAD) is a risk factor for CMD, with a higher prevalence among women.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!